Showing 3971-3980 of 5957 results for "".
- Eyedaptic Unveils AI-Powered Visual Assistant for People with Retinal Disordershttps://modernod.com/news/eyedaptic-unveils-eye6-with-ivy-ai-powered-visual-assistant-for-people-with-retinal-disorders/2482385/Eyedaptic unveiled the EYE6 with Ivy, a wearable vision aid designed to enhance vision and provide an AI-powered visual assistant. The EYE6 is the next generation of Eyedaptic’s smart glasses, which includes Ivy, an interactive visual assistant to help and
- Enrollment Begins for Ocular Therapeutix’s Axpaxli Phase 3 SOL-R Wet AMD Studyhttps://modernod.com/news/ocular-therapeutixs-axpaxli-phase-3-sol-r-wet-amd-study-begins-enrollment/2482382/Ocular Therapeutix announced that the first patients have been enrolled in the phase 3 SOL-R clinical trial evaluating repeat dosing of Axpaxli (axitinib intravitreal implant, also known as OTX-TKI) for the treatment of patients with wet age-related macular degeneration (wet AMD). Accor
- Topcon Launches IS-6500 Ophthalmic Instrument Standhttps://modernod.com/news/topcons-is-6500-ophthalmic-instrument-stand-launched/2482381/Topcon Healthcare announced the launch of the IS-6500 digital instrument stand in the United States, Latin America, and Canada. The IS-6500 stand joins Topcon’s portfolio of ergonomic devices for eye exams. According to the company, the IS-6500 stand incorporates specialized
- OHSU Researchers Discover Link Between Proteins in Tears, Pain After Eye Surgeryhttps://modernod.com/news/ohsu-researchers-discover-link-between-proteins-in-tears-pain-after-eye-surgery/2482376/Researchers at Oregon Health & Science University (OHSU) have discovered a connection between levels of certain proteins found in patients’ tears and persistent pain months after refractive surgery. The team hopes their findings, which were
- Oertli Receives FDA 510(k) Clearance for Faros Surgical Systemhttps://modernod.com/news/oertli-instrumente-ag-achieves-milestone-with-fda-510k-clearance-for-faros-surgical-system/2482371/Oertli Instrumente announced it has received FDA 510(k) clearance for the Faros anterior cataract surgery system. According to a company news release, the Faros system offers a compact design and rapid operational readiness, requiring minimal space in operating rooms. It
- AbbVie Launches Refresh Tears PF and Refresh Relieva PF Xtrahttps://modernod.com/news/abbvie-launches-refresh-tears-pf-and-refresh-relieva-pf-xtra/2482369/AbbVie has introduced two new preservative-free (PF) lubricant eye drop products─Refresh Tears PF and Refresh Relieva PF Xtra. According to AbbVie, the new products contain several new features: Multidose Bottle Design: The bottles
- Bausch + Lomb Acquires Diagnostic Company Trukera Medicalhttps://modernod.com/news/bausch-lomb-acquires-diagnostic-company-trukera-medical/2482368/Bausch + Lomb announced it has acquired US-based privately held ophthalmic medical diagnostic company Trukera Medical. Financial terms of the deal were not disclosed. An affiliate of B+L acquired Trukera from its private equity owner, AccelMed Partners, and other shareholders. 
- EssilorLuxottica Acquires Majority Stake in Heidelberg Engineeringhttps://modernod.com/news/essilorluxottica-acquires-majority-stake-in-heidelberg-engineering/2482362/Optical industry giant EssilorLuxottica announced it has reached a deal to acquire an 80% stake in Germany-based Heidelberg Engineering. Financial terms of the deal were not disclosed. Founded by Dr. Gerhard Zinser and Christoph Schoess in 1990, Heidelberg is a prov
- Heidelberg Engineering Introduces Faster OCT Angiography with Spectralis Shift Technologyhttps://modernod.com/news/heidelberg-engineering-introduces-faster-oct-angiography-with-spectralis-shift-technology/2482359/Heidelberg Engineering has received FDA clearance of the Spectralis OCTA Module with Shift technology, which is designed to reduce acquisition time by 50%.[1] The preset OCTA speed of 125 kHz helps streamline workflow, enhance clinical e
- Claes H. Dohlman, MD, Cornea Research Pioneer and Visionary, Passes Away at 101https://modernod.com/news/claes-h-dohlman-md-cornea-research-pioneer-and-visionary-passes-away-at-101/2482356/Cornea Research Pioneer Claes H. Dohlman, MD, PhD, professor of Ophthalmology, Emeritus, and former Chief and Chair of the Department of Ophthalmology at Mass Eye and Ear and Harvard Medical School (HMS), passed away at the age of 101 on July 14, 2024, Mass Eye and Ear announced on Monday.